Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Sep 9;9(9):e107151.
doi: 10.1371/journal.pone.0107151. eCollection 2014.

Antibodies to the extracellular pore loop of TRPM8 act as antagonists of channel activation

Affiliations

Antibodies to the extracellular pore loop of TRPM8 act as antagonists of channel activation

Silke Miller et al. PLoS One. .

Abstract

The mammalian transient receptor potential melastatin channel 8 (TRPM8) is highly expressed in trigeminal and dorsal root ganglia. TRPM8 is activated by cold temperature or compounds that cause a cooling sensation, such as menthol or icilin. TRPM8 may play a role in cold hypersensitivity and hyperalgesia in various pain syndromes. Therefore, TRPM8 antagonists are pursued as therapeutics. In this study we explored the feasibility of blocking TRPM8 activation with antibodies. We report the functional characterization of a rabbit polyclonal antibody, ACC-049, directed against the third extracellular loop near the pore region of the human TRPM8 channel. ACC-049 acted as a full antagonist at recombinantly expressed human and rodent TRPM8 channels in cell based agonist-induced 45Ca2+ uptake assays. Further, several poly-and monoclonal antibodies that recognize the same region also blocked icilin activation of not only recombinantly expressed TRPM8, but also endogenous TRPM8 expressed in rat dorsal root ganglion neurons revealing the feasibility of generating monoclonal antibody antagonists. We conclude that antagonist antibodies are valuable tools to investigate TRPM8 function and may ultimately pave the way for development of therapeutic antibodies.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: All authors work for a per profit company Amgen Inc. No products from Amgen are promoted. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.

Figures

Figure 1
Figure 1. Alignment of extracellular pore loop sequences.
Alignment of the third extracellular loop sequences of the human, rat and mouse TRPM8 channel and the human TRPA1 and TRPV1 channels. The red line indicates the epitope sequence that ACC-049 was generated against.
Figure 2
Figure 2. ACC-049 is a selective inhibitor of TRPM8.
Specificity of ACC-049 (2.5 µM) for blocking human TRPM8 activation induced by the specific natural agonist cold (A) or synthetic agonist icilin (D). No effect of ACC-049 on noxious cold induced human TRPA1 (B) or heat induced TRPV1 activation (C). Small molecule antagonists AMG9090 and AMG6541 are the positive control for TRPA1 (B) or TRPV1 (C) blockage, respectively. Note the near complete blockade of TRPM8 activation by ACC-049 at 2.5 µM, similar to that by the positive small molecule antagonist control M8-B (A). Neither control IgG, nor peptide-absorbed ACC-049, or peptide alone blocked activation of any of the channels tested (A–D). Values are means of triplicate measures in a single experiment and expressed as percent of control (POC). Agonist induced 45Ca2+ uptake in the absence of antibodies (no Ab) was considered as 100 percent and wells with small molecule antagonists plus 45Ca2+ were set as zero percent.
Figure 3
Figure 3. Cold activation of TRPM8.
Concentration dependent antagonism of cold activation (10°C) of the human (A), rat (B), or mouse (C) TRPM8 channels by ACC-049, control IgG and M8-B measured by 45calcium uptake. Note the right shifted concentration response of ACC-049 on human TRPM8 (A) compared to rat (B) or mouse (C) TRPM8, while the small molecule antagonist positive control M8-B exhibited comparable responses on TRPM8 channels of all species tested (A–C). Values are means of triplicate measures in a single experiment and expressed as percent of control (POC). Cold induced 45Ca2+ uptake was considered as 100 percent and wells with M8-B at 1 µM plus 45Ca2+ were set as zero percent.
Figure 4
Figure 4. Icilin activation of TRPM8.
Concentration dependent antagonism of icilin induced activation of the human (A), rat (B) or mouse (C) TRPM8 channels by ACC-049, control IgG and M8-B measured by 45calcium uptake. Note the right shifted concentration response of ACC-049 on human TRPM8 (A) compared to rat (B) or mouse (C) TRPM8, while the small molecule antagonist positive control M8-B exhibited comparable responses on TRPM8 channels of all species tested (A–C). Values are means of triplicate measures in a single experiment and expressed as percent of control (POC). Icilin induced 45Ca2+ uptake was considered as 100 percent and wells with only assay buffer plus 45Ca2+ were set as zero percent.
Figure 5
Figure 5. Menthol activation of TRPM8.
Concentration dependent antagonism of menthol induced activation of the human (A), rat (B) or mouse (C) TRPM8 channels by ACC-049, control IgG and M8-B measured by 45calcium uptake. Human TRPM8 channel activation was blocked by ACC-049 in a concentration dependent manner (A), but there was no antagonistic effect of ACC-049 on either rat (B) or mouse (C) TRPM8 channels activated by menthol. The small molecule antagonist positive control M8-B exhibited comparable responses on TRPM8 channels of all species tested (A–C). Values are means of triplicate measures and expressed as percent of control (POC). Menthol induced 45Ca2+ uptake was considered as 100 percent and wells with only assay buffer plus 45Ca2+ were set as zero percent.
Figure 6
Figure 6. Icilin activation of TRPM8 in CHO cells and rat DRG neurons.
Antagonism of icilin induced activation of human TRPM8 recombinantly expressed by CHO cells (A) and rat DRG neurons (B) by additional poly- and monoclonal antibodies generated against the third extracellular pore loop. a. Alomone ACC-049. b. MyBiosource MBS609041. c. Creative Diagnostics CABT37242RH. d. Thermo Scientific OST00133W. e. Antibodies Online ABIN351226. f. Lifespan Biosciences LS-B6668. g. Enzo Lifesciences BML-SA664. h. M8-B. i. 1 µM icilin. j. 1 µM icilin + peptide (SDVD GTTYDFAHC). k. Buffer. A. Note the complete block of TRPM8 channel activation by ACC-049 (a), MyBiosource (b) and Enzo Lifesciences (g) antibodies at the single concentration tested. Small molecule positive control M8-B also completely blocked TRPM8 channel activation (h). B. Five out of seven antibodies tested (a, b, e, f, g) block icilin activation of rat DRG neurons by 70–80%, two antibodies (c, d) are ineffective. Values are means of triplicate measures in a single experiment and expressed as percent of control (POC). 45Ca2+ uptake of CHO-TRPM8 cells activated with 1 µM icilin and antigen peptide (j) was considered as 100 percent and wells with only assay buffer plus 45Ca2+ were set as zero percent.

Similar articles

Cited by

References

    1. McKemy DD, Neuhausser WM, Julius D (2002) Identification of a cold receptor reveals a general role for TRP channels in thermosensation. Nature 416: 52–58. - PubMed
    1. McCoy DD, Knowlton WM, McKemy DD (2011) Scraping through the ice: uncovering the role of TRPM8 in cold transduction. Am J Physiol Regul Integr Comp Physiol 300: R1278–1287. - PMC - PubMed
    1. Peier AM, Moqrich A, Hergarden AC, Reeve AJ, Andersson DA, et al. (2002) A TRP channel that senses cold stimuli and menthol. Cell 108: 705–715. - PubMed
    1. Dhaka A, Earley TJ, Watson J, Patapoutian A (2008) Visualizing cold spots: TRPM8-expressing sensory neurons and their projections. J Neurosci 28: 566–575. - PMC - PubMed
    1. Bautista DM, Siemens J, Glazer JM, Tsuruda PR, Basbaum AI, et al. (2007) The menthol receptor TRPM8 is the principal detector of environmental cold. Nature 448: 204–208. - PubMed

Substances

Grants and funding

The authors have no support or funding to report.